An interventional study of suprachoroidal buckling in Retinal Detachment, sponsored by Fang Wang. Status unknown. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2020-08-19.
Sponsored by Fang Wang · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Study of novel surgical technic-suprachoroidal buckling for therapy of rhegmatogenous retinal detachment.It was excpted to reattached the retina and improve visual function of rhegmatogenous retinal detachment patients.
The operation was performed under a surgical microscope with a 25G Chandelier light source and a wide-field observation system to observe the fundus.Location, marking and freezing of the retinal tear on the scleral side .
Subretinal fluid is released from the outside of the sclera as needed. The spherical conjunctiva was opened and the radial full-thickness scleral incision (3mm)was made about 8-13mm away from the retinal tear. A "pocket" is formed by injecting some viscoelastic agent into the posterior edge of the sclera and separating the choroid from the sclera using the Healon packaged cannula (No.27 Rycroft cannula). The Healon 5 syringe was connected with a 450-um special tube (a 23 caliber curved tube with olive tip). The cannula is inserted into the supragromal space under microscopic and was scaned by iOCT . Monitor the location of retinal tear during intubation in real time, and adjust the position of the needle: posterior margin of the tear. Once confirmed in accord with the needle position, sodium hyaluronate injection, injection needles to in front of shift to injection, until the tear was completely surrounded in viscoelastic agent to create the choroid crest, usually need 0.2 mL to 0.5 mL. Exit the duct and close the incision with scleral presutures.
200 studies on the registry are indexed under Retinal Detachment; 30 are open to participants now.
This study's planned enrollment of 15 is below the median of 50 across 133 interventional studies indexed under Retinal Detachment.
Browse Retinal Detachment studies →Fang Wang is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
suprachoroidal buckling for therapy of rhegmatogenous retinal detachment
Procedure: suprachoroidal buckling
Location, marking and freezing of the retinal tear on the scleral side . Subretinal fluid is released from the outside of the sclera as needed. In the quadrant of the retinal tear, the spherical conjunctiva was opened and the radial full-thickness scleral incision (3mm)was made about 8-13mm away from the retinal tear. After the choroid was exposed, a "pocket" is formed by injecting some viscoelastic agent into the posterior edge of the sclera and separating the choroid from the sclera using the Healon packaged cannula (No.27 Rycroft cannula). The Healon 5 syringe was connected with a 450-um special tube . The cannula is inserted into the supragromal space under microscopic and was scaned by iOCT . Once confirmed in accord with the needle position, sodium hyaluronate injection, usually need 0.2 mL to 0.5 mL, application of anterior chamber puncture or subretinal fluid stable intraocular pressure. Exit the duct and close the incision with scleral presutures.
Retina reattachment
Number of participants who achieved retina reattachment assessed by fundus photography,b-scan ultrasonography and optical coherence tomography.
Time frame: 3 months post operation
Best Corrected visual Acuity (BCVA)
Patients' best corrected visual acuity assessed by logarithmic visual acuity charts.
Time frame: 3 months post operation
Intraocular pressure (IOP)
Patients' IOP assessed by noncontact tonometer
Time frame: 3 months post operation
Treatment-related adverse event
Number of participants with treatment-related adverse events(including suprachoroidal hemorrhage, subretinal hemorrhage, vitreous hemorrhage)
Time frame: 3 months post operation
Retina reattachment
Number of participants who achieved retina reattachment assessed by fundus photography,b-scan ultrasonography and optical coherence tomography.
Time frame: 12 months post operation
Best Corrected visual Acuity (BCVA)
Patients' best corrected visual acuity assessed by logarithmic visual acuity charts.
Time frame: 12 months post operation
Intraocular pressure (IOP)
Patients' IOP assessed by noncontact tonometer
Time frame: 12 months post operation
Treatment-related adverse event
Number of participants with treatment-related adverse events(including suprachoroidal hemorrhage, subretinal hemorrhage, vitreous hemorrhage)
Time frame: 12 months post operation
No study locations are listed for this record.
Plan to share: Yes — Summarize the experience and deficiency of clinical research process and operation technology, and complete the preliminary report of clinical research.
Supporting information: Study protocol, Clinical study report
Time frame: 2021.01.31 The follow-up work of the study subjects was completed, and statistical analysis was conducted 2021.10.31 Continue to complete the follow-up of all patients, and make statistical analysis of all the data, and scientifically evaluate the results; Summarize the experience and deficiency of clinical research process and operation technology, and complete the preliminary report of clinical research.
Access criteria: All access
Start is estimated for Sep 2020; primary completion for Oct 2020, 1 month later.
Of 55 non-industry interventional studies with no phase under Retinal Detachment, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 49. This study's planned 1 month is below that.
Counting every sponsor, half of 56 studies reached it within 23 months; a quarter within 12 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fang Wang